Bachem Holding AG (BCHMF)

Market Cap	5.37B
Revenue (ttm)	667.92M
Net Income (ttm)	132.70M
Shares Out	n/a
EPS (ttm)	1.77
PE Ratio	40.49
Forward PE	34.36
Dividend	1.03 (1.68%)
Ex-Dividend Date	May 5, 2025

Volume	150
Average Volume	797
Open	61.43
Previous Close	64.05
Day's Range	61.43 - 61.43
52-Week Range	61.43 - 97.06
Beta	1.01
RSI	43.07
Earnings Date	Jul 24, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,207
• Stock Exchange: OTCMKTS
• Ticker Symbol: BCHMF

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF